Novo Nordisk
NVO
NVO
659 hedge funds and large institutions have $9.35B invested in Novo Nordisk in 2020 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 193 increasing their positions, 270 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
659
Holders Change
+16
Holders Change %
+2.49%
% of All Funds
13.55%
Holding in Top 10
16
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-23.81%
% of All Funds
0.33%
New
71
Increased
193
Reduced
270
Closed
49
Calls
$79.4M
Puts
$32.5M
Net Calls
+$47M
Net Calls Change
+$42.2M
Top Buyers
| 1 |
Capital International Investors
Los Angeles,
California
|
+$170M |
| 2 |
Renaissance Technologies
New York
|
+$55.6M |
| 3 |
Fayez Sarofim & Co
Houston,
Texas
|
+$54.9M |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$47.5M |
| 5 |
Two Sigma Investments
New York
|
+$24.6M |
Top Sellers
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$594M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$169M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$82.9M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
-$75.2M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$54.1M |
